Prognostic Value With Combined ONSD and NIRS Measurements for Predicting Neurological Outcome After Cardiac Arrest
NCT ID: NCT05552794
Last Updated: 2024-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2020-12-12
2022-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasonic Measurement of the Optic Nerve Sheath Diameter Predicting Outcome After Cardiac Arrest
NCT04084054
Optic Nerve Sheath Diameter in Hypertensive Emergency
NCT06286696
Cerebrovascular Hemodynamics in Patients With ARDS.
NCT03949738
Hospital-wide Incidence, Clinical Characteristics and Outcomes of ARDS
NCT03546699
Comparison of Two Strategies to Realize Apnea Test for the Diagnostic of Brain Death in Potential Organ Donors (CPAPNEE STUDY)
NCT01649726
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
On the other hand, Near-Infrared Spectroscopy (NIRS) measures the total oxygen saturation in a given tissue volume by approximating the oxygen saturation of the hemoglobin fraction in the terminal vasculature. With this method, regional oxygen saturation (rSO2) of the brain tissue can be measured noninvasively. In general, post-hypoxic brain injury after cardiac arrest, changes in oxygen consumption, cerebral blood flow or cerebral blood volume may be associated with rSO2 changes in brain tissue. Therefore, using frontal brain rSO2 continuous bedside NIRS monitoring, additional information can be obtained about the early prediction of reliable neurological outcomes. However, some studies show that reliable prognostic results with NIRS monitoring are limited.
Thanks to the combined use of ultrasonography and bedside noninvasive measurements such as ONSD and NIRS, early prediction of the neurological outcomes of cardiac arrest patients with ROSC can positively change the treatment management of this patient group in ICUs with high sensitivity and better neurological outcomes can be achieved.
In this study, the prognostic values of combined ultrasonographic ONSD and NIRS measurements will investigate in predicting neurological outcomes after cardiac arrest.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Good outcome
Good outcome was defined as cerebral performance category (CPC): 1-2
Optic nerve Sheath Diameter (ONSD)
ONSD and rSO2 monitoring will perform when the patients arrived in ICU.
Poor outcome
Poor outcome was defined as cerebral performance category (CPC): 3-5
Optic nerve Sheath Diameter (ONSD)
ONSD and rSO2 monitoring will perform when the patients arrived in ICU.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Optic nerve Sheath Diameter (ONSD)
ONSD and rSO2 monitoring will perform when the patients arrived in ICU.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* GCS ≤6 after arrest,
* age ≥18,
* brain tomography taken within the first 6 hours after the arrest,
* targeted heat management (TTM) applied
* sedated patients
Exclusion Criteria
* cardiac arrest due to intracranial trauma or neurological event,
* patients with previous cerebrovascular accident,
* patients who have affected the orbit or eyeball patients with facial trauma,
* patients with ocular pathology such as exophthalmos, glaucoma or cataracts,
* patients who have been or should be sedated,
* those with recurrent CA within three days of ICU admission
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nevsehir Public Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mehmet Akif Yazar, MD
Assoc. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mehmet Akif Yazar
Role: PRINCIPAL_INVESTIGATOR
Konya City Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Konya City Hospital
Konya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-1-19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.